InsidersTradesSigma
EQL Pharma AB: management transactions · Finland · FIN-FSA
FI:eql-pharma-ab-6d1436SE0005497732FI·FIN-FSAMcap 772M€Healthcare
Browse the full management transaction log of EQL Pharma AB, a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, EQL Pharma AB has published 8 public disclosures. Market capitalisation: €772.2m. The latest transaction was reported on 27 March 2026 — Sale. Among the most active insiders: Axel Schörling. The full history is free.
8
Insider Decl.
0
Thresholds
€100,159
3 ops.
Buy Volume
€118,679
2 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
26.15 €
Analyst consensus
1 analystsStrong buy
50.00 €Target 50.00 €(+91%)50.00 €
Income statement
Revenue373.5 M€
Gross profit156.0 M€42% margin
Net income43.1 M€-1.9% margin
Valuation
PER (trailing)62.3x
PER (forward)10.6x
P/Book2.9x
Balance sheet & cash
Market cap772.2 M€
Total debt455.7 M€
Free Cash Flow−270.5 M€
Profitability & ownership
ROE-1.1%
ROA-0.6%
% insiders61.1%
% institutions16.1%
Last declaration on 27 March 2026
Declarations8 total
Executives●Sale31FIN-FSA
€113,45624,066 shares@ €4.71440.015% mcap54.7% of flow
Aktie
FI:A003X402-1·
Executives●Purchase19FIN-FSA
€6,1451,000 shares@ €6.14510.0008% mcap100.0% of flow
Aktie
FI:A003S651-1·
Ideal exit: 20 Jun 2026 (T+270)
Executives●Sale19FIN-FSA
€5,223667 shares@ €7.83030.0007% mcap100.0% of flow
Aktie
FI:A003S329-1·
Executives●Other26FIN-FSA
0289,155 shares0
Aktie
FI:A003S161-1·
Executives●Other15FIN-FSA
038,370 shares0
Aktie
FI:A003S141-2·
Executives●Purchase30FIN-FSA
€66,061100,000 shares@ €0.66060.0086% mcap31.8% of flow
Teckningsoption
FI:A003R671-1·
Ideal exit: 20 May 2026 (T+270)
Executives●Purchase27FIN-FSA
€27,9533,650 shares@ €7.65830.0036% mcap13.5% of flow
Aktie
FI:A003O464-1·
Ideal exit: 10 Feb 2026 (T+270)
8 of 8 declarations